Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial

OBJECTIVE:To determine whether the administration of recombinant human erythropoietin (rHuEPO) to critically ill patients in the intensive care unit (ICU) would reduce the number of red blood cell (RBC) transfusions required. DESIGN:A prospective, randomized, double-blind, placebo-controlled, multic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care medicine 1999-11, Vol.27 (11), p.2346-2350
Hauptverfasser:	Corwin, Howard L, Gettinger, Andrew, Rodriguez, Robert M, Pearl, Ronald G, Gubler, K Dean, Enny, Christopher, Colton, Theodore, Corwin, Michael J
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Critical Illness - mortality Critical Illness - therapy Double-Blind Method Erythrocyte Transfusion Erythropoietin - therapeutic use Female Hematocrit Humans Intensive Care Units Length of Stay Male Medical sciences Middle Aged Pharmacology. Drug treatments Prospective Studies Recombinant Proteins Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!